Skip to content

New York, USA, Dec. 21, 2022 (GLOBE NEWSWIRE) — The Neurostimulation Devices market was valued at USD 4,796 Million in 2021 and will reach USD 50.7 Billion by 2030, with a CAGR of 12.8%. Chronic pain patients can receive neurostimulation using neurostimulator devices to reduce some of the symptoms caused by various conditions. Nerve stimulators allow patients to test the effectiveness of the treatment before committing to it for a longer period of time, unlike other pain management procedures.

Shop directly from the latest Neurostimulation devices market the report published in Aug-2022. Click the link below to start shopping.

Neurostimulation Devices Market Insights.

  • In 2021, the spinal cord stimulators segment maintained the maximum position in the market with 51.5% of revenue based on product.
  • By application, the pain management segment ruled the entire market in 2021 with a revenue share of 68.0%.
  • North America had a significant market position in 2021 with the largest market share at 60%.

Factors Affecting the Growth of Neurostimulation Devices Market:

Factors such as: Increasing incidence of neurological disorders and investments in neurological research and development are influencing the expansion of the market.

  • The increasing incidence of neurological diseases is driving the need for advanced neurostimulation devices. For example, Parkinson’s disease affects approximately 1 million Americans, with at least 60,000 new cases each year, and Alzheimer’s is the sixth leading cause of death. The market will grow in the coming years due to the overall increase in neurological disorders.
  • To remain competitive in the market, major players spend on clinical trials. For example, Boston Scientific Corporation is conducting clinical trials to examine patient satisfaction with chronic low back and extremity pain management using a new implantable neurostimulation system.

Neurostimulation Devices Market Segmentation Analysis

Neurostimulation Devices market segmentation is done on the basis of application, product, and region.

By: Product:

  • A deep brain stimulator
  • Spinal cord stimulator
  • Vagus nerve stimulator
  • Sacral nerve stimulator
  • Electric stomach stimulator

By application

  • Epilepsy
  • Chronic pain
  • Urinary and fecal incontinence
  • Parkinson’s disease
  • Migraine
  • Depression
  • Trembling
  • The others

For the region

North America


  • Japan
  • India
  • China
  • Rest of Asia Pacific


  • Great Britain.
  • France
  • Germany
  • Italy
  • Spain
  • The rest of Europe

The rest of the world

  • African region and the Middle East
  • Latin America

To get a first preview of the report, request a sample here

In 2021, the spinal cord stimulators segment maintained the maximum position in the market with 51.5% of revenue based on product. This is due to the wide range of product applications and significant market penetration of commercially available products. Spinal cord stimulators are used to treat non-malignant chronic neuropathic pain that produces small nerve impulses without causing physiological changes in the target region.

By application, the pain management segment ruled the entire market in 2021 with a revenue share of 68.0%. The expansion of this market is due to increasing cases of chronic pain and increasing consumption of products for pain management because of its significant therapeutic value.

North America held a significant position in the market in 2021 with the largest market share of 60% due to the growing elderly population and incidence of neurological diseases. Preference for minimally invasive therapies and increasing awareness of mental illnesses are contributing to increasing demand for neurostimulation devices. In addition, the market will expand due to increasing R&D expenditure for the development of the latest neurostimulation devices.

Neurostimulation Devices Market Report Coverage

Report-Feature Details
Total market size in 2020 4.796 billion USD
Projected revenue for 2030 50.7 billion USD
Growth rate CAGR of nearly 12.8%
Base year taken 2021
Historical data 2017 – 2020
Forecast period 2021 – 2030
Quantitative units Revenue in Million USD / Billion, Volume in 000 Units and CAGR from 2020 to 2030
Report coverage Volume forecast, revenue forecast, competitive landscape, growth factors and trends
Fragment coverage Product, Application and Region
Regional framework Latin America, North America, Europe, Middle East and Africa;
The circle of the earth Canada; USA; Great Britain; Deutschland; France; Italy; Spain; India; Russian Federation; Singapore; China; Japan; South Korea; Australia; Mexico; Argentina; Brazil; South Africa; Saudi Arabia; UAE
Companies included Cyberonics; Medronic; St. Jude Medical, Inc.; Nevro Corp, Boston Scientific Corp.
Personalization scope Free report customization with purchase. Additional or change in regional, country and sector scope.
Purchase and Pricing Options Use specialized shopping choices to meet your exact research needs.

To read the executive summary of the report, visit:

Key Players in the Neurostimulation Devices Market:

  • Nevro Corp.
  • NeuroSigma, Inc.
  • EndoStim Inc.
  • Neutronics Inc.
  • Aleva Therapeutics SA
  • Boston Scientific Corp.
  • Medtronic PLC
  • Jude Medical, Inc.
  • Cyberonics
  • ElectroCore Inc.
  • Synapse Biomedical Inc.
  • NeuroPace Inc.

Recent developments

  • In December 2022, Abbott announced that its Eterna System device had received FDA approval. Eterna is the smallest rechargeable spinal cord stimulation implant designed to treat the signs and symptoms of chronic pain.
  • In July 2022, according to a release from Dyansys Inc., the US Food and Drug Administration approved First Relief, a PENS (percutaneous electrical neurostimulation) device that can be used in multiple sessions for up to 56 days for symptomatic relief of chronic, incurable conditions. : pain caused by diabetic peripheral neuropathy.

Related reports

Market for non-fusion spinal devices

The Spinal Non-Fusion Devices Market Report analyzes its growth factors, challenges, constraints, opportunities, etc. The Non-Fusion Spinal Devices market was valued at USD 3.88 Billion in 2021 and will reach USD 6.08 Billion by 2030 at a CAGR of 5.1%. Growing elderly population and increasing spinal disorders are driving the market expansion. Significant market participants include Medtronic, DePuy Synthes, Stryker Corporation, etc.

Recombinant DNA technology market

SMR’s Recombinant DNA Technologies market report overviews factors such as restraints, challenges, drivers, and opportunities. The Recombinant DNA Technology market is valued at USD 707.20 billion in 2021 and will reach USD 1378.76 billion, growing at a CAGR of 7.7%. Factors such as investment in R&D, producing transgenic animals, genetically modified crops and vaccines are driving the market expansion. Major players in the industry are BASF, Amgen, Bayer, DuPont Pioneer, etc.

Air compressors market

The SMR Air Compressor market provides detailed insights into its driving factors, challenges, restraints, etc. The Air Compressor market was valued at USD 39.10 Billion in 2021 and will reach USD 51.59 Billion by 2030 at a CAGR of 3.74%. Use in the food and beverage industry has increased investment in the oil and gas sector, and increased use in the manufacturing sector is influencing the growth rate of this market. Important players in this market are Atlas Copco AB, General Electric Company, Hitachi, Ltd., Sulzer, Ltd. etc.

The carbon black market

The Carbon Black market report outlines factors such as opportunities, restraints, challenges, and others. The carbon black market was valued at USD 13.45 billion in 2021 and will reach USD 21.85 billion by 2030 at a CAGR of 15%. Increasing usage in plastics, coatings and manufacturing industries is expanding the market growth rate. The major players in the market are Ralson, Cabot Corporation, Philips Carbon Black Limited, Orion Engineered Carbons GmbH, etc.

Ceramic Matrix Composites Market

The SMR Ceramic Matrix Composites market report analyzes its growth drivers, challenges, restraints, opportunities, etc. The Ceramic Matrix Composites market was valued at USD 8.65 Billion in 2021 and will reach USD 22.25 Billion by 2030 at a CAGR of 11%. Increasing need for lightweight and fuel-efficient vehicles, growing demand in the automotive sector, and use of CMC in the aerospace industry are driving the market expansion. Important players in the market are 3M Company, Ultramet, Lancer Systems, COI Ceramics, etc.

About us:
Strategic Market Research assists organizations in making key business decisions globally by providing Collaborative and customized research reports that are highly accurate in terms of market figures. We believe that every company, be it a start-up in the introductory phase of the Product Life Cycle or an established company in the growth phase, requires market research services to streamline its core business plan. This may be related to Product Launch, Go-to-Market strategies, competitive analysis or new geographic penetration and expansion.

Contact us.
Strategic Market Research LLP.
Sunil Kumar
India: +91-8260836500
Email: [email protected]
Press Release:

Join us.



Leave a Reply

Your email address will not be published. Required fields are marked *